학술논문

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study
Document Type
Review Article
Source
In ESMO Open December 2021 6(6)
Subject
Language
ISSN
2059-7029